Stanley Druckenmiller acquired 660 Thousand AbCellera Biologics shares worth $3.3 Million. That's 0.12% of their equity portfolio (48th largest holding). The first AbCellera Biologics trade was made in Q4 2020. Since then Stanley Druckenmiller bought shares one more times and sold shares on one occasions. The investor's estimated purchase price is $11.7 Million, resulting in a loss of 72%.